Coartem News
Most Popular Coartem Story
FDA panel backs Novartis malaria drug
Novartis has won the unanimous support of an FDA expert committee on the efficacy of its malaria drug Coartem, with only one holdout on the safety vote. Novartis has asked for the agency's approval... Read more...
Latest Headlines
- December 4, 2008
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
